Panacea Biotec

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE922B01023
  • NSEID: PANACEABIO
  • BSEID: 531349
INR
383.70
7.85 (2.09%)
BSENSE

Sep 22, 03:30 PM

BSE+NSE Vol: 1.54 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
27.78
27.78
27.78
27.78
27.78
27.78
Share Warrants & Outstandings
Total Reserve
807.06
807.01
814.27
815.82
848.86
-256.47
Shareholder's Funds
834.84
834.79
842.05
843.60
876.64
-228.69
Minority Interest
-5.96
-4.17
-3.82
-3.50
-2.98
-3.00
Long-Term Borrowings
23.66
22.21
20.99
20.22
34.16
819.53
Secured Loans
0.00
0.00
0.00
0.24
0.29
759.50
Unsecured Loans
23.66
22.21
20.99
19.98
33.87
60.03
Deferred Tax Assets / Liabilities
23.14
23.28
22.55
20.37
-23.75
-0.15
Other Long Term Liabilities
1.19
11.31
22.28
34.24
45.59
194.41
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
36.61
35.34
27.80
26.55
29.16
30.65
Total Non-Current Liabilities
84.61
92.14
93.61
99.22
85.10
959.99
Current Liabilities
Trade Payables
189.60
225.76
153.68
177.32
234.72
246.66
Other Current Liabilities
119.61
104.88
119.46
116.21
505.64
104.64
Short Term Borrowings
0.00
0.00
0.00
0.06
0.05
84.45
Short Term Provisions
39.48
36.36
35.69
36.14
35.95
13.35
Total Current Liabilities
348.69
366.99
308.83
329.73
776.37
449.09
Total Liabilities
1,262.18
1,289.75
1,240.67
1,271.17
1,735.12
1,177.38
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
1,368.47
1,326.91
1,311.87
1,330.83
1,317.48
1,261.62
Less: Accumulated Depreciation
808.44
775.79
742.62
730.88
695.41
652.92
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
560.03
551.12
569.26
599.95
622.07
608.70
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
99.97
93.51
74.72
28.01
4.91
21.24
Intangible assets under development
44.12
34.54
26.78
14.32
12.35
13.18
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
15.57
15.87
12.66
0.07
0.07
0.07
Long Term Loans & Advances
21.97
15.23
70.96
56.76
21.46
17.62
Other Non Current Assets
7.46
3.01
1.11
9.74
123.70
5.61
Total Non-Current Assets
749.13
713.27
755.49
708.85
784.56
666.41
Current Assets Loans & Advances
Current Investments
10.03
3.15
40.36
13.42
5.00
0.00
Inventories
192.79
213.67
177.94
202.09
212.72
174.14
Sundry Debtors
73.52
72.56
57.42
60.09
81.66
84.68
Cash and Bank
64.37
106.97
139.48
225.99
583.28
135.79
Other Current Assets
10.10
8.27
7.12
6.42
6.41
48.38
Short Term Loans and Advances
162.24
171.86
62.86
54.31
61.49
67.98
Total Current Assets
513.05
576.47
485.18
562.32
950.55
510.97
Net Current Assets (Including Current Investments)
164.36
209.48
176.34
232.59
174.19
61.88
Total Current Assets Excluding Current Investments
503.02
573.32
444.81
548.90
945.55
510.97
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,262.18
1,289.75
1,240.67
1,271.17
1,735.12
1,177.38
Contingent Liabilities
416.47
367.09
369.39
655.75
368.17
406.99
Total Debt
23.66
22.21
20.99
20.16
34.10
735.08
Book Value per share (adjusted)
132.76
132.76
133.94
134.2
139.59
-40.87
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 6.53% vs 5.81% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is -89.48% vs -49.24% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 2.38% vs 0.10% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is -1.89% vs 25.36% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -11.00% vs 18.82% in Mar 2025

Compare Balance Sheet Results of Panacea Biotec
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
27.78
10.55
17.23
163.32%
Share Warrants & Outstandings
Total Reserve
807.06
570.28
236.78
41.52%
Shareholder's Funds
834.84
580.84
254.00
43.73%
Minority Interest
-5.96
0.00
-5.96
0.00%
Long-Term Borrowings
23.66
0.00
23.66
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
23.66
0.00
23.66
0.00%
Deferred Tax Assets / Liabilities
23.14
-0.45
23.59
5,242.22%
Other Long Term Liabilities
1.19
2.25
-1.06
-47.11%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
36.61
3.33
33.28
999.40%
Total Non-Current Liabilities
84.61
5.13
79.48
1,549.32%
Current Liabilities
Trade Payables
189.60
238.49
-48.89
-20.50%
Other Current Liabilities
119.61
50.75
68.86
135.68%
Short Term Borrowings
0.00
29.88
-29.88
-100.00%
Short Term Provisions
39.48
1.81
37.67
2,081.22%
Total Current Liabilities
348.69
320.93
27.76
8.65%
Total Liabilities
1,262.18
906.90
355.28
39.18%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,368.47
336.14
1,032.33
307.11%
Less: Accumulated Depreciation
808.44
145.48
662.96
455.71%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
560.03
190.66
369.37
193.73%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
99.97
56.16
43.81
78.01%
Intangible assets under development
44.12
3.44
40.68
1,182.56%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
15.57
0.00
15.57
0.00%
Long Term Loans & Advances
21.97
5.38
16.59
308.36%
Other Non Current Assets
7.46
1.75
5.71
326.29%
Total Non-Current Assets
749.13
280.05
469.08
167.50%
Current Assets Loans & Advances
Current Investments
10.03
268.37
-258.34
-96.26%
Inventories
192.79
61.82
130.97
211.86%
Sundry Debtors
73.52
227.40
-153.88
-67.67%
Cash and Bank
64.37
1.81
62.56
3,456.35%
Other Current Assets
10.10
1.82
8.28
454.95%
Short Term Loans and Advances
162.24
65.62
96.62
147.24%
Total Current Assets
513.05
626.85
-113.80
-18.15%
Net Current Assets (Including Current Investments)
164.36
305.92
-141.56
-46.27%
Total Current Assets Excluding Current Investments
503.02
358.48
144.54
40.32%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,262.18
906.90
355.28
39.18%
Contingent Liabilities
416.47
0.00
416.47
0.00%
Total Debt
23.66
29.88
-6.22
-20.82%
Book Value per share (adjusted)
132.76
275.20
-142.44
-51.76%
Annual - Borrowings
Borrowings 23.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.53% vs 5.81% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.19 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -89.48% vs -49.24% in Mar 2025

Annual - Fixed Assets
Fixed Assets 660.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.38% vs 0.10% in Mar 2025

Annual - Investments
Investments 15.57 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -1.89% vs 25.36% in Mar 2025

Annual - Current Assets
Current Assets 513.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -11.00% vs 18.82% in Mar 2025